Annual Current Liabilities
$7.44 M
-$7.06 M-48.68%
December 31, 2022
Summary
- As of February 10, 2025, LMNL annual total current liabilities is $7.44 million, with the most recent change of -$7.06 million (-48.68%) on December 31, 2022.
- During the last 3 years, LMNL annual current liabilities has fallen by -$16.49 million (-68.90%).
Performance
LMNL Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
$6.97 M
+$232.10 K+3.44%
June 30, 2023
Summary
- As of February 10, 2025, LMNL quarterly total current liabilities is $6.97 million, with the most recent change of +$232.10 thousand (+3.44%) on June 30, 2023.
- Over the past year, LMNL quarterly current liabilities has dropped by -$13.20 million (-65.44%).
Performance
LMNL Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
LMNL Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -48.7% | -65.4% |
| 3 y3 years | -68.9% | -65.8% |
| 5 y5 years | -74.0% | -72.1% |
LMNL Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -48.7% | at low | -65.4% | -4.2% |
| 5 y | 5-year | -68.9% | at low | -70.9% | -4.2% |
| alltime | all time | -77.3% | -83.4% | -79.0% | -85.3% |
Liminal BioSciences Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $6.97 M(+3.4%) |
| Mar 2023 | - | $6.74 M(-9.5%) |
| Dec 2022 | $7.44 M(-48.7%) | $7.44 M(+11.5%) |
| Sep 2022 | - | $6.68 M(-66.9%) |
| Jun 2022 | - | $20.17 M(+4.5%) |
| Mar 2022 | - | $19.31 M(+33.1%) |
| Dec 2021 | $14.50 M(-22.2%) | $14.50 M(-14.9%) |
| Sep 2021 | - | $17.05 M(-24.4%) |
| Jun 2021 | - | $22.55 M(+19.8%) |
| Mar 2021 | - | $18.83 M(+0.9%) |
| Dec 2020 | $18.65 M(-22.1%) | $18.65 M(+2.9%) |
| Sep 2020 | - | $18.12 M(-11.2%) |
| Jun 2020 | - | $20.40 M(+16.6%) |
| Mar 2020 | - | $17.50 M(-26.9%) |
| Dec 2019 | $23.93 M(-8.8%) | $23.93 M(+6.6%) |
| Sep 2019 | - | $22.46 M(+10.5%) |
| Jun 2019 | - | $20.32 M(-38.8%) |
| Mar 2019 | - | $33.20 M(+26.6%) |
| Dec 2018 | $26.23 M(-8.4%) | $26.23 M(+5.3%) |
| Sep 2018 | - | $24.90 M(-0.4%) |
| Jun 2018 | - | $25.00 M(-5.4%) |
| Mar 2018 | - | $26.42 M(-7.8%) |
| Dec 2017 | $28.64 M(+20.5%) | $28.64 M(+8.1%) |
| Sep 2017 | - | $26.50 M(+14.8%) |
| Jun 2017 | - | $23.08 M(+17.5%) |
| Mar 2017 | - | $19.64 M(-17.4%) |
| Dec 2016 | $23.78 M(+138.8%) | $23.78 M(+49.7%) |
| Sep 2016 | - | $15.88 M(+63.0%) |
| Jun 2016 | - | $9.75 M(-11.8%) |
| Mar 2016 | - | $11.04 M(+10.9%) |
| Dec 2015 | $9.96 M(-69.6%) | $9.96 M(+16.7%) |
| Sep 2015 | - | $8.53 M(-2.5%) |
| Jun 2015 | - | $8.75 M(-72.5%) |
| Mar 2015 | - | $31.77 M(-3.0%) |
| Dec 2014 | $32.74 M(+40.6%) | $32.74 M(+10.4%) |
| Sep 2014 | - | $29.65 M(+19.3%) |
| Jun 2014 | - | $24.86 M(-1.0%) |
| Mar 2014 | - | $25.10 M(+7.8%) |
| Dec 2013 | $23.28 M(+77.2%) | $23.28 M(+16.3%) |
| Sep 2013 | - | $20.01 M(+92.3%) |
| Jun 2013 | - | $10.41 M(-2.6%) |
| Mar 2013 | - | $10.68 M(-18.7%) |
| Dec 2012 | $13.14 M(+13.5%) | $13.14 M(-31.8%) |
| Sep 2012 | - | $19.26 M(+18.0%) |
| Jun 2012 | - | $16.32 M(+8.4%) |
| Mar 2012 | - | $15.05 M(+30.1%) |
| Dec 2011 | $11.57 M(+30.7%) | $11.57 M(-43.9%) |
| Sep 2011 | - | $20.61 M(+16.2%) |
| Jun 2011 | - | $17.74 M(-2.6%) |
| Mar 2011 | - | $18.22 M(+105.8%) |
| Dec 2010 | $8.85 M | $8.85 M(-4.6%) |
| Sep 2010 | - | $9.28 M(+9.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | $8.46 M(-34.7%) |
| Mar 2010 | - | $12.96 M(+3.2%) |
| Dec 2009 | $12.56 M(+15.9%) | $12.56 M(+1.4%) |
| Sep 2009 | - | $12.38 M(-7.6%) |
| Jun 2009 | - | $13.40 M(+13.4%) |
| Mar 2009 | - | $11.81 M(+9.0%) |
| Dec 2008 | $10.83 M(-7.5%) | $10.83 M(-2.5%) |
| Sep 2008 | - | $11.11 M(-15.7%) |
| Jun 2008 | - | $13.17 M(-3.2%) |
| Mar 2008 | - | $13.61 M(+16.2%) |
| Dec 2007 | $11.71 M(+0.0%) | $11.71 M(-2.9%) |
| Sep 2007 | - | $12.06 M(+15.8%) |
| Jun 2007 | - | $10.41 M(+5.9%) |
| Mar 2007 | - | $9.83 M(-16.0%) |
| Dec 2006 | $11.71 M(+88.0%) | $11.71 M(+6.4%) |
| Sep 2006 | - | $11.00 M(-3.4%) |
| Jun 2006 | - | $11.39 M(+23.3%) |
| Mar 2006 | - | $9.24 M(+48.3%) |
| Dec 2005 | $6.23 M(-20.6%) | $6.23 M(+9.5%) |
| Sep 2005 | - | $5.69 M(-30.5%) |
| Jun 2005 | - | $8.19 M(-5.4%) |
| Mar 2005 | - | $8.65 M(+10.3%) |
| Dec 2004 | $7.84 M(+21.9%) | $7.84 M(+92.3%) |
| Sep 2004 | - | $4.08 M(-1.1%) |
| Jun 2004 | - | $4.12 M(-25.4%) |
| Mar 2004 | - | $5.53 M(-14.1%) |
| Dec 2003 | $6.44 M(+133.5%) | $6.44 M(+104.3%) |
| Sep 2003 | - | $3.15 M(-3.8%) |
| Jun 2003 | - | $3.28 M(+25.6%) |
| Mar 2003 | - | $2.61 M(-5.3%) |
| Dec 2002 | $2.76 M(+34.6%) | $2.76 M(+38.7%) |
| Sep 2002 | - | $1.99 M(-12.5%) |
| Jun 2002 | - | $2.27 M(+11.5%) |
| Mar 2002 | - | $2.04 M(-0.5%) |
| Dec 2001 | $2.05 M(+65.9%) | $2.05 M(+14.4%) |
| Sep 2001 | - | $1.79 M(+56.0%) |
| Jun 2001 | - | $1.15 M(+12.1%) |
| Mar 2001 | - | $1.02 M(-17.0%) |
| Dec 2000 | $1.23 M(-25.2%) | $1.23 M(-25.4%) |
| Sep 2000 | - | $1.66 M(+53.3%) |
| Jun 2000 | - | $1.08 M(-17.4%) |
| Mar 2000 | - | $1.31 M(-20.8%) |
| Dec 1999 | $1.65 M(-76.8%) | $1.65 M(+10.1%) |
| Sep 1999 | - | $1.50 M(-86.8%) |
| Jun 1999 | - | $11.37 M(+22.5%) |
| Mar 1999 | - | $9.28 M(+30.6%) |
| Dec 1998 | $7.11 M(+292.6%) | $7.11 M(+104.3%) |
| Sep 1998 | - | $3.48 M(+10.9%) |
| Jun 1998 | - | $3.14 M(+78.6%) |
| Mar 1998 | - | $1.76 M(+4.9%) |
| Dec 1997 | - | $1.67 M |
| Sep 1997 | $1.81 M | - |
FAQ
- What is Liminal BioSciences annual total current liabilities?
- What is the all time high annual current liabilities for Liminal BioSciences?
- What is Liminal BioSciences annual current liabilities year-on-year change?
- What is Liminal BioSciences quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Liminal BioSciences?
- What is Liminal BioSciences quarterly current liabilities year-on-year change?
What is Liminal BioSciences annual total current liabilities?
The current annual current liabilities of LMNL is $7.44 M
What is the all time high annual current liabilities for Liminal BioSciences?
Liminal BioSciences all-time high annual total current liabilities is $32.74 M
What is Liminal BioSciences annual current liabilities year-on-year change?
Over the past year, LMNL annual total current liabilities has changed by -$7.06 M (-48.68%)
What is Liminal BioSciences quarterly total current liabilities?
The current quarterly current liabilities of LMNL is $6.97 M
What is the all time high quarterly current liabilities for Liminal BioSciences?
Liminal BioSciences all-time high quarterly total current liabilities is $33.20 M
What is Liminal BioSciences quarterly current liabilities year-on-year change?
Over the past year, LMNL quarterly total current liabilities has changed by -$13.20 M (-65.44%)